Articles written by: Sherman Chang

Immuron Limited (IMRN) and Corcept Therapeutics Incorporated (NASDAQ:CORT) Contrasting side by side

Both Immuron Limited (NASDAQ:IMRN) and Corcept Therapeutics Incorporated (NASDAQ:CORT) are each other’s competitor in the Biotechnology industry. Thus the compare of their institutional ownership, earnings and valuation, profitability, risk, dividends, analyst recommendations. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Immuron Limited 4 0.00 […]

Comparing of Northern Trust Corporation (NTRSP) and The India Fund Inc. (NYSE:IFN)

Northern Trust Corporation (NASDAQ:NTRSP) and The India Fund Inc. (NYSE:IFN), both competing one another are Asset Management companies. We will compare their dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Northern Trust Corporation 25 […]

Silvercrest Asset Management Group Inc. (SAMG)’s Financial Results Comparing With B. Riley Financial Inc. (NASDAQ:RILY)

Both Silvercrest Asset Management Group Inc. (NASDAQ:SAMG) and B. Riley Financial Inc. (NASDAQ:RILY) are each other’s competitor in the Asset Management industry. Thus the compare of their dividends, analyst recommendations, institutional ownership, profitability, risk, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings […]

TKK Symphony Acquisition Corporation (TKKSU) and Tiberius Acquisition Corporation (NASDAQ:TIBRU) Contrasting side by side

TKK Symphony Acquisition Corporation (NASDAQ:TKKSU) and Tiberius Acquisition Corporation (NASDAQ:TIBRU) have been rivals in the Conglomerates for quite some time. Below is a review of each business including various aspects such as dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership. Valuation & Earnings Gross Revenue Price/Sales Ratio Net […]

Comparing of Surface Oncology Inc. (SURF) and Rubius Therapeutics Inc. (NASDAQ:RUBY)

This is therefore a comparing of the institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation in Surface Oncology Inc. (NASDAQ:SURF) and Rubius Therapeutics Inc. (NASDAQ:RUBY). The two are both Biotechnology companies that compete with one another. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Comparing of Liminal BioSciences Inc. (LMNL) and AMAG Pharmaceuticals Inc. (NASDAQ:AMAG)

Liminal BioSciences Inc. (NASDAQ:LMNL) and AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) compete against each other in the Biotechnology sector. We will compare them and contrast their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Liminal BioSciences […]

Rigel Pharmaceuticals Inc. (RIGL)’s Financial Results Comparing With Hepion Pharmaceuticals Inc. (NASDAQ:HEPA)

We will be comparing the differences between Rigel Pharmaceuticals Inc. (NASDAQ:RIGL) and Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) as far as institutional ownership, earnings and valuation, profitability, risk, dividends, analyst recommendations are concerned. The two businesses are rivals in the Biotechnology industry. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings […]

SELLAS Life Sciences Group Inc. (SLS)’s Financial Results Comparing With Acer Therapeutics Inc. (NASDAQ:ACER)

We are comparing SELLAS Life Sciences Group Inc. (NASDAQ:SLS) and Acer Therapeutics Inc. (NASDAQ:ACER) on their institutional ownership, earnings and valuation, profitability, risk, dividends, analyst recommendations. They both are Biotechnology companies, competing one another. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio SELLAS Life […]